HDL from end-stage renal disease patients exhibits superior cardioprotection and increase in S1P
European Journal of Clinical Investigation Nov 30, 2017
Brinck JW, et al. - As a part of this study, authors comparatively analyzed the plasma levels of sphingosine-1-phosphate (S1P), high-density lipoprotein (HDL)-associated S1P (HDL-S1P) and HDL-mediated protection against oxidative stress between chronic kidney disease (CKD) and control patients. Uremic HDL was discovered to be more effective than control HDL for safeguarding the cardiomyocytes against oxidative stress. This data was elucidated through its higher S1P content which previously appeared to be the determinant of HDL-mediated cardioprotective capacity. It was perceived that lower concentrations of albumin in CKD were related to higher HDL-S1P.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries